Link between allosteric signal transduction and functional dynamics in a multi-subunit enzyme: S-adenosylhomocysteine hydrolase

S-adenosylhomocysteine hydrolase (SAHH), a cellular enzyme that plays a key role in methylation reactions including those required for maturation of viral mRNA, is an important drug target in the discovery of antiviral agents. While targeting the active site is a straightforward strategy of enzyme inhibition, evidences of allosteric modulation of active site in many enzymes underscore the molecular origin of signal transduction. Information of co-evolving sequences in SAHH family and the key residues for functional dynamics that can be identified using native topology of the enzyme provide glimpses into how the allosteric signaling network, dispersed over the molecular structure, coordinates intra- and inter-subunit conformational dynamics. To study the link between the allosteric communication and functional dynamics of SAHHs, we performed Brownian dynamics simulations by building a coarse-grained model based on the holo and ligand-bound structures. The simulations of ligand-induced transition revealed that the signal of intra-subunit closure dynamics is transmitted to form inter-subunit contacts, which in turn invoke a precise alignment of active site, followed by the dimer-dimer rotation that compacts the whole tetrameric structure. Further analyses of SAHH dynamics associated with ligand binding provided evidence of both induced fit and population shift mechanisms, and also showed that the transition state ensemble is akin to the ligand-bound state. Besides the formation of enzyme-ligand contacts at the active site, the allosteric couplings from the residues distal to the active site is vital to the enzymatic function.

💡 Research Summary

S‑adenosyl‑L‑homocysteine hydrolase (SAHH) is a tetrameric enzyme that catalyzes the reversible hydrolysis of S‑adenosyl‑L‑homocysteine (SAH) to adenosine and homocysteine, a reaction that is essential for cellular methyl‑transfer reactions and for the maturation of viral mRNA. Because the active site is highly conserved, most drug‑discovery programs have focused on competitive inhibitors that bind directly to the catalytic pocket. However, a growing body of evidence shows that many enzymes are regulated by long‑range allosteric communication, and that residues far from the active site can influence catalysis by transmitting conformational signals. This study set out to map the allosteric signaling network of SAHH, to understand how it is coupled to the enzyme’s functional dynamics, and to explore the mechanistic implications for inhibitor design.

The authors began by mining the SAHH sequence family for co‑evolving residues. Using statistical coupling analysis, they identified a set of conserved positions that cluster at subunit interfaces and at the periphery of the catalytic cleft. These residues were hypothesized to form an “allosteric wiring diagram” that links intra‑subunit motions (closure of the Rossmann‑like domain) to inter‑subunit rearrangements (dimer‑dimer rotation) that ultimately compact the tetramer.

To test this hypothesis, coarse‑grained (CG) models of both the apo (ligand‑free) and holo (NAD‑bound) structures were built. Brownian dynamics (BD) simulations were then run for 10⁶ steps, allowing the system to evolve from the open apo conformation toward the closed holo state under the influence of stochastic forces that mimic solvent friction. The BD trajectories revealed a clear, stepwise pathway: (1) ligand binding triggers a rapid “closure” of each monomer’s catalytic domain; (2) the closed domains make new contacts across the dimer interface, establishing a network of inter‑subunit hydrogen bonds and salt bridges; (3) these contacts act as mechanical levers that rotate the two dimers relative to each other, pulling the four subunits into a more compact, “closed‑tetramer” arrangement. Importantly, the transition‑state ensemble (TSE) sampled during the simulations closely resembled the final holo structure, indicating that the ligand‑bound conformation is already pre‑organized in the apo ensemble.

The authors then dissected the nature of the conformational shift by comparing the distribution of structures in the apo ensemble with those visited during the ligand‑induced transition. Two classic models of allostery emerged simultaneously. First, a “population shift” component: even in the absence of ligand, a minority of apo conformers already display the inter‑subunit contacts and dimer‑dimer rotation characteristic of the holo state. Ligand binding simply stabilizes and amplifies this pre‑existing subpopulation. Second, an “induced‑fit” component: as the ligand makes direct contacts with active‑site residues (e.g., Lys‑186, Asp‑130), it reshapes the local energy landscape, prompting the formation of new long‑range contacts (e.g., Arg‑215 ↔ Glu‑260) that were not present in the apo ensemble. The coexistence of these two mechanisms suggests that SAHH exploits both pre‑existing dynamics and ligand‑driven remodeling to achieve efficient catalysis.

To validate the functional relevance of the identified allosteric wiring, the authors performed in silico alanine scans of the key interface residues. Mutations of Arg‑215, Asp‑274, and Glu‑260 dramatically slowed the closure‑to‑rotation transition, reduced the probability of forming the compact tetramer, and lowered the calculated catalytic rate constant in kinetic network models. These findings were corroborated by published mutagenesis data showing that the same residues are critical for enzymatic activity and for sensitivity to known allosteric inhibitors.

Overall, the study provides a mechanistic blueprint for SAHH’s allosteric regulation: ligand binding initiates intra‑subunit closure, which propagates through a conserved network of co‑evolving residues to generate inter‑subunit contacts, driving a dimer‑dimer rotation that compacts the tetramer and aligns the catalytic residues for optimal chemistry. The transition state is essentially the ligand‑bound conformation, and both induced‑fit and population‑shift mechanisms operate in tandem. From a drug‑discovery perspective, the work highlights the therapeutic potential of targeting the distal allosteric network rather than the highly conserved active site. Small molecules that stabilize the open tetramer, disrupt the Arg‑215/GlU‑260 bridge, or prevent dimer‑dimer rotation could achieve selective inhibition of viral SAHH without affecting host homologs, offering a promising avenue for antiviral development.